Rybelsus Semaglutide 7mg 30’ct UK Imported
Rybelsus is a brand name for the medication semaglutide, which is used to treat type 2 diabetes. Semaglutide belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It helps lower blood sugar levels in people with type 2 diabetes by increasing insulin production and reducing the amount of glucose produced by the liver.
Oral GLP-1 Agonist
Rybelsus is the first and only oral GLP-1 receptor agonist approved for the treatment of type 2 diabetes. Most other GLP-1 agonists are injectable medications. The oral formulation allows for more convenient dosing.
Imported from the UK
The 7mg 30-count bottle of Rybelsus you mentioned is an imported product from the United Kingdom. The availability and packaging may differ from the US version.
Dosing Schedule
- The starting dose is 3mg once daily for 30 days
- The dose is then increased to 7mg once daily for at least 30 days
- After at least 30 days on 7mg, the dose may be increased to 14mg once daily if needed for better blood sugar control
-
-
Original price was: ₨99,999.00.₨79,999.00Current price is: ₨79,999.00.
Description
Rybelsus is a brand name for the medication semaglutide, which is used to treat type 2 diabetes. Semaglutide belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It helps lower blood sugar levels in people with type 2 diabetes by increasing insulin production and reducing the amount of glucose produced by the liver.
Oral GLP-1 Agonist
Rybelsus is the first and only oral GLP-1 receptor agonist approved for the treatment of type 2 diabetes. Most other GLP-1 agonists are injectable medications. The oral formulation allows for more convenient dosing.
Imported from the UK
The 7mg 30-count bottle of Rybelsus you mentioned is an imported product from the United Kingdom. The availability and packaging may differ from the US version.
Dosing Schedule
- The starting dose is 3mg once daily for 30 days
- The dose is then increased to 7mg once daily for at least 30 days
- After at least 30 days on 7mg, the dose may be increased to 14mg once daily if needed for better blood sugar control
Unique Dosing Instructions
Rybelsus must be taken on an empty stomach with a sip of water at least 30 minutes before the first food, beverage, or other oral medications of the day. This is to ensure proper absorption of the medication.
Potential for Cardiovascular Benefits
In clinical trials, semaglutide has shown potential to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. This is an area of ongoing research.
Key Benefits
- Significantly lowers A1C levels in adults with type 2 diabetes when taken daily along with diet and exercise
- May help with some weight loss, though it is not an approved weight loss medication
- Does not increase the risk of major cardiovascular events like heart attack or stroke
Key Ingredients
The active ingredient in Rybelsus is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide:
- Mimics the function of natural incretin hormones that help control blood sugar levels
- Stimulates insulin secretion and reduces glucagon secretion when blood glucose is high
- Slows gastric emptying to make you feel full
Other ingredients in the Rybelsus tablets include:
- Magnesium stearate
- Microcrystalline cellulose
- Povidone
- Salcaprozate sodium (SNAC)
- Silica, colloidal anhydrous                                                          Here is a summary of the mechanism of action for Rybelsus (semaglutide):    Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the effects of the natural GLP-1 hormone in the body :
- Rybelsus binds to and activates the GLP-1 receptor, which is found in various tissues including the pancreas, stomach, and brain .
- By activating the GLP-1 receptor, Rybelsus stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. This helps lower blood glucose levels .
- Rybelsus also delays gastric emptying, which slows the rate at which food leaves the stomach. This can help promote feelings of fullness and reduce appetite .
- The structural modifications made to semaglutide, the active ingredient in Rybelsus, help protect it from being rapidly broken down by the enzyme DPP-4. This prolongs the activity of the GLP-1 receptor agonist .
- An absorption enhancer called SNAC is included in the Rybelsus formulation to enable oral administration of semaglutide, rather than requiring an injection like other GLP-1 agonists .
SemaglutideAntidiabetic and anti-obesity medicationMoreUsesTreatment of type 2 diabetes and long-term weight managementApproval Year in the US2017Administration MethodsSubcutaneous injection or orallyThe molecular formula of semaglutide is C187H291N45O59.
Dosage
- Start at 3mg once daily for 30 days, then increase to 7mg once daily
- After 30 days on 7mg, may increase to 14mg once daily if needed
- Take on empty stomach, at least 30 mins before first food/drink of day
Storage
- Store at room temperature (68-77°F)
- Keep in original bottle with desiccant cap
Reviews
- Significantly lowers HbA1c in clinical trials
- Common side effects include nausea, diarrhea, vomiting
- Convenient once-daily oral dosing, but strict timing requirements
Overall, Rybelsus is an effective oral GLP-1 agonist for type 2 diabetes, with specific dosing and storage needs, and generally positive reviews from users.
Reviews
There are no reviews yet.